期刊文献+
共找到79,446篇文章
< 1 2 250 >
每页显示 20 50 100
Risk of progression to high-grade intraepithelial neoplasia and gastric cancer:A multi-center prospective study in Anhui Province,China 被引量:2
1
作者 Ying-Ling Liu Jie Liu Ye-Tao Wang 《World Journal of Gastrointestinal Oncology》 2025年第3期155-164,共10页
BACKGROUND Gastric cancer is one of the most common cancers worldwide,especially in East Asia.AIM To explore the clinical outcomes and progression-related factors of low-grade intraepithelial neoplasia(LGIN)in the gas... BACKGROUND Gastric cancer is one of the most common cancers worldwide,especially in East Asia.AIM To explore the clinical outcomes and progression-related factors of low-grade intraepithelial neoplasia(LGIN)in the gastric mucosa and provide valuable guidance for improving treatment efficacy.METHODS A total of 357 patients diagnosed with LGIN based on initial pathological examination in Anhui Provincial Hospital or three other medical consortium units between January 2022 and June 2024 were included.Among them,296 patients were followed up with endoscopic and biopsy pathology.Logistic regression was utilized to analyze the relevant risk factors for LGIN progression in the gastric mucosa.RESULTS The distribution sites of LGIN among the 357 patients were as follows:Gastric antrum(54.6%),gastric cardia(24.1%),gastric angulus(8.7%),gastric body(4.8%),gastric fundus(4.8%),and multiple sites(3.1%).Additionally,of the 357 patients with LGIN,112(31.4%)developed ulceration and 59(16.5%)experienced gastric polyps.Furthermore,231 of the 357(64.71%)patients with LGIN tested positive for Helicobacter pylori(H.pylori)infection.The H.pylori infection rates of the patients with LGIN with accompanying atrophy,intestinal metaplasia,and gastric ulcer were 51.95%,59.31%,and 28.57%,respectively.Multivariate logistic regression analysis showed that age≥60 years[odds ratio(OR)=3.063,95%confidence interval(CI):1.351-6.945,P=0.007],H.pylori infection(OR=3.560,95%CI:1.158-10.949,P=0.027),multiple locations(OR=10.136,95%CI:2.045-50.237,P=0.005),lesion size≥2 cm(OR=3.921,95%CI:1.664-9.237,P=0.002),and gastric ulcer(OR=2.730,95%CI:1.197-6.223,P=0.017)were predictive factors for LGIN progression.CONCLUSION LGIN progression is closely related to age,H.pylori positivity,multiple locations,lesion size≥2 cm,and gastric ulcer.Thus,actively identifying these risk factors in patients with LGIN may have certain clinical significance in preventing further tumor progression. 展开更多
关键词 Low-grade intraepithelial neoplasia Gastric cancer progression Risk factor Prospective study
暂未订购
Oncogenic and tumor-suppressive roles of Lipocalin 2(LCN2)in tumor progression 被引量:1
2
作者 BAOXING HUANG ZICHANG JIA +3 位作者 CHENCHEN FU MOXIAN CHEN ZEZHUO SU YUNSHENG CHEN 《Oncology Research》 2025年第3期567-575,共9页
Lipocalin-2(LCN2)is a member of the lipocalin superfamily with multiple functions and can participate in the transport of a variety of small lipophilic ligands in vivo.LCN2 is significantly expressed in various tumors... Lipocalin-2(LCN2)is a member of the lipocalin superfamily with multiple functions and can participate in the transport of a variety of small lipophilic ligands in vivo.LCN2 is significantly expressed in various tumors and plays an important role in regulating tumor cell proliferation,invasion,and metastasis.The specific actions of LCN2 in tumors may vary depending on the particular type of cancer involved.In this review,we provide an extensive overview of the transcriptional and post-transcriptional regulation of LCN2 in health and disease.Furthermore,we summarize the impact of LCN2 dysregulation in a broad range of tumors.Lastly,we examine the mechanisms of action of LCN2 during tumorigenesis,progression,and metastasis.Understanding the complex relationships between LCN2 and tumor development,progression,and metastasis is vital for advancing our knowledge of cancer biology,developing biomarkers for diagnosis and clinical decision-making,and creating therapeutic strategies to improve the management of patients with cancer. 展开更多
关键词 Tumor progression Gene regulation ONCOGENESIS Lipocalin 2(LCN2)
暂未订购
Predictors of Survival and Relapse among Children Diagnosed with Acute Leukemia in Northen Tanzania
3
作者 Arnold Likiliwike Yotham Gwanika +3 位作者 Heronima Joas Aisa Shayo Linda Kissila Esther Majaliwa 《Open Journal of Pediatrics》 2025年第1期52-65,共14页
Background: Acute Leukemia is the most common childhood cancer, with two main types: ALL and AML. In Tanzania, recent improvements in treatment and survival have been noted, but the latest data is from 2013. This stud... Background: Acute Leukemia is the most common childhood cancer, with two main types: ALL and AML. In Tanzania, recent improvements in treatment and survival have been noted, but the latest data is from 2013. This study will update survival and relapse information from 2013 to 2020 to help enhance future treatment strategies. Methodology: This study was conducted at two tertiary hospitals in Tanzania. The study analyzed data from children diagnosed with Acute Leukemia between January 2015 to December 2020. Patient data were collected via questionnaires and analyzed using STATA software. Results: This study included a total of 95 participants 64 had age less than 10 years and majority were males 56.8%, 55 had duration of symptoms for more than 1 month 66 had ALL, 49 had attained remission, the overall three years survival was 44.2% with those children with no health insurance having high risk of dying, rate of relapse was 18.4%, with those diagnosed with B-ALL having low risk of relapse. Conclusion: This study provides insights into survival and relapse predictors for childhood leukemia in northern Tanzania. It found an overall survival rate of 44.2%, with health insurance and minimal residual disease after induction being key predictors of survival. The relapse rate was 18.4%, with health insurance linked to a lower relapse risk. Health insurance emerged as a strong predictor of better survival, leading to the recommendation that all children should have health insurance. Additionally, the study suggests that policymakers should support the expansion of global health coverage in Tanzania. 展开更多
关键词 Acute Leukemia relapse SURVIVAL
暂未订购
Efficacy Study of Molecular Diagnostic Techniques for Monitoring Tuberculosis Relapse
4
作者 Huai Huang 《Journal of Clinical and Nursing Research》 2025年第5期60-66,共7页
The purpose of this article is to analyze the efficacy of molecular diagnostic techniques for monitoring tuberculosis relapse.After analyzing the connotation of molecular diagnostic techniques and their specific appli... The purpose of this article is to analyze the efficacy of molecular diagnostic techniques for monitoring tuberculosis relapse.After analyzing the connotation of molecular diagnostic techniques and their specific application process in tuberculosis relapse monitoring,a total of 200 cured tuberculosis patients were selected(100 in the experimental group and 100 in the control group).During the 12-month follow-up period,the experimental group was monitored by molecular diagnostic techniques,while the control group was monitored by traditional techniques.Finally,by comparing the performance indicators of the two monitoring methods,as well as the relapse situations and outcomes of patients,it was demonstrated that molecular diagnostic techniques have higher efficacy in tuberculosis relapse monitoring. 展开更多
关键词 Molecular diagnosis TUBERCULOSIS relapse monitoring Target amplification
暂未订购
Real-world pilot of case management in schizophrenia:exploring factors influencing patient participation,potential for relapse prevention and effects on diverse clinical outcomes
5
作者 Xiao Zhang Tong Geng +7 位作者 Ling Yu Jingjing Li Dongying Han Jianfang Xu Tianzi Wang Ruisheng Yun Guizhong Yao Jia Cheng 《General Psychiatry》 2025年第2期153-158,共6页
To the editor:Schizophrenia is a chronic and severe mental disorder characterised by profound disruptions in thinking,affecting language,perception and the sense of self. These disruptions can significantly impair an ... To the editor:Schizophrenia is a chronic and severe mental disorder characterised by profound disruptions in thinking,affecting language,perception and the sense of self. These disruptions can significantly impair an individual’s ability to function socially and occupationally, leading to a high burden on both the individuals affected and society as a whole. 展开更多
关键词 patient participation relapse prevention clinical outcomes mental disorder SCHIZOPHRENIA case management
暂未订购
Advances in precision diagnosis and treatment,and translational medicine research for refractory relapsed multiple myeloma
6
作者 Wei Fu Jun-Li Wang +2 位作者 Guo-Bin Cheng Lin-Ya Lyu Hu-Lin Wang 《Cancer Advances》 2025年第6期1-9,共9页
Multiple myeloma is a complex and challenging blood cancer,particularly in cases where the disease has relapsed or become resistant to treatment.These situations often have a significant impact on both patient surviva... Multiple myeloma is a complex and challenging blood cancer,particularly in cases where the disease has relapsed or become resistant to treatment.These situations often have a significant impact on both patient survival and quality of life.Over recent years,advances in precision medicine and translational medicine have brought about a shift in treatment strategies,moving toward more personalized and targeted approaches.This review highlights the latest developments in the management of refractory and relapsed multiple myeloma,focusing on the current state of precision diagnosis and treatment,the role of translational medicine,and potential future directions in research.By reviewing key studies and clinical trial data,we aim to offer fresh perspectives and strategies that could improve clinical outcomes. 展开更多
关键词 multiple myeloma refractory relapsed precision medicine translational medicine treatment strategies
暂未订购
Can reinforcement learning effectively prevent depression relapse?
7
作者 Haewon Byeon 《World Journal of Psychiatry》 2025年第8期71-79,共9页
Depression is a prevalent mental health disorder characterized by high relapse rates,highlighting the need for effective preventive interventions.This paper reviews the potential of reinforcement learning(RL)in preven... Depression is a prevalent mental health disorder characterized by high relapse rates,highlighting the need for effective preventive interventions.This paper reviews the potential of reinforcement learning(RL)in preventing depression relapse.RL,a subset of artificial intelligence,utilizes machine learning algorithms to analyze behavioral data,enabling early detection of relapse risk and optimization of personalized interventions.RL's ability to tailor treatment in real-time by adapting to individual needs and responses offers a dynamic alternative to traditional therapeutic approaches.Studies have demonstrated the efficacy of RL in customizing e-Health interventions and integrating mobile sensing with machine learning for adaptive mental health systems.Despite these advantages,challenges remain in algorithmic complexity,ethical considerations,and clinical implementation.Addressing these issues is crucial for the successful integration of RL into mental health care.This paper concludes with recommendations for future research directions,emphasizing the need for larger-scale studies and interdisciplinary collaboration to fully realize RL’s potential in improving mental health outcomes and preventing depression relapse. 展开更多
关键词 Reinforcement learning Depression relapse prevention Personalized treatment Machine learning Mental health interventions
暂未订购
Progression of myopia among school-aged children in Guangzhou,China
8
作者 Kun Huang Zhi-Dan Wu +3 位作者 Ze-Hao Chen Jin Chen Zhuo-Ming Tang Rong Lin 《International Journal of Ophthalmology(English edition)》 2025年第8期1561-1569,共9页
AIM:To investigate the prevalence and characteristics of myopia in school-aged students and effects of environmental and genetic factors on the progression of myopia.METHODS:A total of 2422 students aged between 5 and... AIM:To investigate the prevalence and characteristics of myopia in school-aged students and effects of environmental and genetic factors on the progression of myopia.METHODS:A total of 2422 students aged between 5 and 18y from nine schools in Baiyun District of Guangzhou,China were sampled using a stratified sampling method in 2020.Among them,1066 students participated in the follow-up survey the following year.Data were obtained based on ocular examinations and a questionnaire survey conducted during two visits.Factors potentially influencing the progression of myopia were analyzed.RESULTS:During the year assessed in this study,the percentage of students with myopia increased from 58.4%to 64.8%(P=0.002).Spherical equivalent(SE)progressed from-1.44±1.91 diopters(D)at baseline to-1.66±1.10 D(P=0.005).A generalized estimating equation(GEE)model revealed that age[adjusted odds ratio(aOR)=1.298,P<0.001],residential students(aOR=2.428,P=0.018),parental myopia(one myopic parent:aOR=1.553,both parents myopic:aOR=2.609,P<0.001),frequent reading of books or viewing of screens in direct sunlight(aOR=3.502,P=0.023),using only overhead lighting for reading and writing at night(aOR=1.633,P=0.011),parental restrictions on exercise time(aOR=2.286,P=0.012),and having less than 2h of outdoor exercise per day during the past week(aOR=1.584,P=0.019)were all identified as independent risk factors for progression of myopia.CONCLUSION:Our findings in this study indicate that age,residential students,parental myopia,indoor lighting environment,and physical activity have significant effects on the progression of myopia,providing evidence for further in-depth mechanistic interpretation and efficient intervention strategies for school-age children in this area. 展开更多
关键词 school-age children PREVALENCE progression of myopia
原文传递
Correction:LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis
9
作者 YUANLIN LIU YAN LIU +4 位作者 YAN WANG QIANG WANG YAN YAN DANDAN ZHANG HUIQIN LIU 《Oncology Research》 2025年第6期1505-1505,共1页
In the article“LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis”(Oncology Research,2024,Vol 32,No.7,pp.1221-1229.doi:10.32604/or.2024.047454),there were some errors in the content.In ... In the article“LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis”(Oncology Research,2024,Vol 32,No.7,pp.1221-1229.doi:10.32604/or.2024.047454),there were some errors in the content.In order to ensure the scientific and rigorous nature of our academic publications,we deleted the incorrect content that is not related to this study,supplemented the details of the method. 展开更多
关键词 cervical cancer PCGEM miR p KIF B lncrna progression
暂未订购
Aberrant Sialylation in Ovarian Cancer:Orchestrating Progression,Metastasis,and Therapeutic Hurdles
10
作者 Yu-xin Chen Guang-nian Zhao Qing-lei Gao 《Current Medical Science》 2025年第3期395-404,共10页
Ovarian cancer(OC),a highly lethal gynaecological malignancy,is often diagnosed at advanced stages,resulting in a poor prognosis.Sialylation,an important form of glycosylation,significantly contributes to the progress... Ovarian cancer(OC),a highly lethal gynaecological malignancy,is often diagnosed at advanced stages,resulting in a poor prognosis.Sialylation,an important form of glycosylation,significantly contributes to the progression of various solid tumours,including OC.Aberrant sialylation promotes tumour progression and metastasis by altering the structure and function of glycoproteins.Although its role in several solid tumours is well documented,the role of abnormal sialylation in OC and its potential as a therapeutic target remain poorly understood.This review highlights sialylation as a key regulator of the progression,metastasis,and drug resistance of OC.A deeper understanding of altered sialylation can contribute to the identification of novel therapeutic strategies for OC. 展开更多
关键词 Ovarian cancer SIALYLATION Immune evasion Tumor progression METASTASIS SIALYLTRANSFERASE
暂未订购
Splenic histiocytic sarcoma:Disease progression from the perspective of pathophysiology
11
作者 Meng-Ting Yao Tao Wang +3 位作者 Hao Luo Meng-Yuan Yao Kai Chen Yong-Qiang Zhu 《World Journal of Clinical Cases》 2025年第28期91-97,共7页
Splenic histiocytic sarcoma(SHS)is a rare,aggressive hematological malignancy with unclear progression and management.Our case illustrates the progression and pathophysiological processes of SHS and provides key data ... Splenic histiocytic sarcoma(SHS)is a rare,aggressive hematological malignancy with unclear progression and management.Our case illustrates the progression and pathophysiological processes of SHS and provides key data for the diagnosis,treatment and management of SHS.A 60-year-old female with incidentally detected splenic mass(6.0 cm×5.7 cm)underwent splenectomy,confirmed as SHS in 2020.Post-op imatinib therapy was given.In 2022,hepatic metastases(2.4 cm×2.9 cm)with pancytopenia led to supportive care.Lesions enlarged to 4.3 cm×2.7 cm,leading to multi-organ failure and death at 33 months.The case was categorized into three distinct stages based on the pathophysiology of SHS:Early-stage splenic tumor growth,mid-stage liver metastasis with hematological abnormalities,and late-stage tumor infiltration leading to multiorgan failure.For SHS,this case highlights the pivotal role of early intervention and the value of personalized treatment strategies. 展开更多
关键词 Splenic histiocytic sarcoma Hemophagocytic syndrome PATHOPHYSIOLOGY Disease progression THERAPY
暂未订购
Microbiota and cancer:Elucidating the role of Candida albicans in cancer progression
12
作者 Di Wang Hao-Ling Zhang +3 位作者 Hao-Long Zhang Zhi-Jing Song Sandai Doblin Ping Lu 《World Journal of Clinical Oncology》 2025年第6期23-33,共11页
Candida albicans(C.albicans)represents one of the most prevalent opportunistic fungal pathogens in cancer patients.Although the association between C.albicans and cancer has been recognized for decades,the causal rela... Candida albicans(C.albicans)represents one of the most prevalent opportunistic fungal pathogens in cancer patients.Although the association between C.albicans and cancer has been recognized for decades,the causal relationship,whether C.albicans infection is a consequence of cancer or a direct contributor to cancer development-remains a subject of intensive investigation.Recently,the complex interplay between microbes and cancer has garnered significant attention within the scientific community,with growing interest in elucidating the underlying molecular mechanisms.This review systematically examines the biological characteristics of C.albicans,its multifaceted interactions with the host,and its relationship with the intestinal microbiota.Additionally,it provides a comprehensive analysis of the association between C.albicans and the development of various malignancies,with particular emphasis on digestive tract cancers.The review also identifies critical knowledge gaps and apparent contradictions in existing research,highlighting potential avenues for breakthroughs that will advance the efficient and accurate screening,diagnosis,and treatment of cancer. 展开更多
关键词 Candida albicans Cancer progression Immune evasion Inflammatory response Tumor microenvironment
暂未订购
CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy
13
作者 Hui Luo Tongjuan Li +5 位作者 Fankai Meng Zhenya Hong Yang Cao Gaoxiang Wang Liang Huang Xiaoxi Zhou 《Cancer Biology & Medicine》 2025年第5期496-501,共6页
CD5-positive(CD5+)diffuse large B-cell lymphoma(DLBCL)represents a special subgroup of DLBCL with a more aggressive disease course and is more likely to develop into relapsed/refractory(r/r)DLBCL in response to immuno... CD5-positive(CD5+)diffuse large B-cell lymphoma(DLBCL)represents a special subgroup of DLBCL with a more aggressive disease course and is more likely to develop into relapsed/refractory(r/r)DLBCL in response to immunochemotherapy.The incidence of CD5+DLBCL is 5%–10%among DLBCL patients1. 展开更多
关键词 OUTCOMES standard therapy incidence relapsed refractory diffuse large b cell lymphoma cd positive car t cell therapy
暂未订购
A Study on the Correlation between Fear of Disease Progression, Perceived Control, and Medical Coping in Patients with Coronary Heart Disease after PCI
14
作者 Xue Li Ziyue Gai +3 位作者 Xinyi Wang Shan Zhang Fang Liu Baohua Cao 《Journal of Clinical and Nursing Research》 2025年第3期215-223,共9页
This study aims to understand the current status of fear of disease progression(FoP)in patients with coronary heart disease(CHD)following percutaneous coronary intervention(PCI),and to explore the relationship between... This study aims to understand the current status of fear of disease progression(FoP)in patients with coronary heart disease(CHD)following percutaneous coronary intervention(PCI),and to explore the relationship between FoP levels,perceived control,and medical coping strategies in these patients.A total of 360 CHD patients who underwent PCI at Xijing Hospital in Shaanxi Province between June and November 2024 were selected using a convenience sampling method.Surveys included a general information questionnaire,the Fear of Progression Questionnaire-Short Form(FoP-Q-SF),the revised Control Attitudes Scale(CAS-R),and the Medical Coping Modes Questionnaire(MCMQ).Pearson correlation analysis was used to examine the relationships between disease perception,positive coping strategies,and FoP.A total of 360 patients completed the study.The average score for FoP in patients with CHD after PCI was 31.64±4.61.FoP was negatively correlated with perceived control(r=-0.106,P<0.01)and medical coping(r=-0.194,P<0.01).Multivariate regression analysis showed that the type of intervention,family history of CHD,smoking status,perceived control,and total medical coping score were significant factors influencing FoP(P<0.01).Enhancing perceived control and identifying positive coping strategies can improve FoP levels in patients with CHD after PCI.Therefore,clinicians should focus on perceived control and medical coping levels in patients and develop targeted interventions to alleviate negative emotions related to FoP. 展开更多
关键词 Coronary heart disease Fear of disease progression Social support CORRELATION
暂未订购
Association between lifestyle factors and disease progression in patients with colorectal polyps and early-stage cancer
15
作者 Fang-Fang Lin Jun-Ting Ye +2 位作者 Xia-Yan Mao Xue-Juan Mao Hui-Hua Ye 《World Journal of Gastrointestinal Oncology》 2025年第8期277-285,共9页
BACKGROUNDColorectal cancer(CRC)typically progresses from benign colorectal polyps,whichrepresent a precursor to malignancy.Identifying the factors influencing thisprogression is crucial for early intervention and pre... BACKGROUNDColorectal cancer(CRC)typically progresses from benign colorectal polyps,whichrepresent a precursor to malignancy.Identifying the factors influencing thisprogression is crucial for early intervention and prevention.Although genetic andenvironmental factors have been widely studied,the role of lifestyle factors suchas physical activity,diet,smoking,sleep,and stress remains underexplored,especially in patients with early stage CRC or polyps.Recent evidence suggeststhat lifestyle behaviors may influence cancer progression by modulating inflammatorypathways,metabolic health,and immune function.For instance,highlevels of physical activity are linked to a reduced risk of CRC development,whereas poor dietary habits,smoking,and inadequate sleep have all beenimplicated in increased cancer risk and progression.Moreover,early-stage CRCpatients,who are often asymptomatic or have minimal symptoms,may particularlybenefit from lifestyle modifications to slow disease progression andimprove overall prognosis.The gap in understanding the specific influence ofthese lifestyle factors on colorectal polyps and early stage cancer progressionunderscores the need for comprehensive studies.By assessing several modifiablelifestyle factors and their association with disease progression,clinicians canidentify practical intervention points.These interventions could ultimately reducethe need for more aggressive treatments and improve the long-term outcomes inaffected patients.AIMTo investigate the association between lifestyle factors and disease progression inpatients with colorectal polyps and early stage cancer.METHODSIn this observational study conducted from January 2022 to December 2023,werecruited 120 patients with colorectal polyps or early stage cancer from Jiangshan People's Hospital.Lifestyle factors,including physical activity,dietary patterns,smoking status,sleep quality,andstress levels,were assessed using validated questionnaires.Disease progression was evaluated using standardizedfollow-up colonoscopies and pathological examinations.Cox proportional hazards models were used to analyzethe association between lifestyle factors and disease progression after adjusting for potential confounders.RESULTSDuring the median follow-up of 18.4 months,42(35.0%)patients experienced disease progression.High levels ofphysical activity were associated with reduced progression risk[adjusted hazard ratio(HR)0.55,95%confidenceinterval(CI):0.38-0.80,P=0.002]compared to low activity levels.High adherence to a healthy dietary patternshowed similar protective effects(adjusted HR 0.62,95%CI:0.43-0.89,P=0.009).Current smoking(adjusted HR1.92,95%CI:1.35-2.73,P<0.001)and poor sleep quality(adjusted HR 1.38,95%CI:1.05-1.82,P=0.021)wereassociated with increased progression risk.The impact of lifestyle factors was particularly pronounced in patientsyounger than 60 years and those with multiple polyps at baseline.CONCLUSIONThis study demonstrated significant associations between lifestyle factors and disease progression in colorectalpolyps and early stage cancer.Physical activity,dietary patterns,smoking status,and sleep quality have emergedas key modifiable factors influencing disease progression.These findings support the integration of lifestyleassessments and modifications in the clinical management of patients with colorectal neoplasia. 展开更多
关键词 Colorectal polyps Disease progression Lifestyle factors Early stage cancer Health behavior
在线阅读 下载PDF
Relationship between uncertainty in illness and fear of progression among lung cancer patients: The chain mediation model
16
作者 Yi-Ling Yang Xue-Qing Zhang +3 位作者 Yong-Qiang Yang Er-Mao Li Bo Zhou You-Wen Gong 《World Journal of Psychiatry》 2025年第5期193-202,共10页
BACKGROUND Uncertainty in illness(UI)and fear of progression(FoP)are significant psycho-logical challenges for lung cancer patients.Coping styles and social support are critical mediators,influencing patients'abil... BACKGROUND Uncertainty in illness(UI)and fear of progression(FoP)are significant psycho-logical challenges for lung cancer patients.Coping styles and social support are critical mediators,influencing patients'ability to manage the emotional and psy-chological burden of UI and FoP.However,limited research has explored the chain mediation effect of these factors on the relationship between UI and FoP,particularly among Chinese lung cancer patients.Convenience sampling was used to recruit inpatients diagnosed with lung cancer at a tertiary hospital in Changde City between November and December 2023.A total of 320 participants completed the Mishel Uncertainty in Illness Scale,Simp-lified Coping Style Questionnaire,Mandarin Chinese Version of the Medical Outcomes Study Social Support Survey,and Fear of Progression Questionnaire-Short Form.The chain mediation analysis was performed using the PROCESS macro to examine the relationships between the variables.RESULTS The results revealed that UI had a significant direct effect on FoP(effect=0.224,95%CI:0.136-0.408).Additionally,three indirect pathways were identified:(1)Social support(effect=0.128,95%CI:0.045-0.153);(2)Coping style(effect=0.115,95%CI:0.048-0.157);and(3)Chain mediators involving social support and coping style(effect=0.072,95%CI:0.045-0.120).The total indirect effect of the three mediation paths is 31.5%.These results confirm that social support and coping style significantly mediate the relationship between UI and FoP.CONCLUSION Based on cross-sectional data and a chain mediation model,this study explored the mechanisms between UI,social support,coping style,and FOP.Patients with lung cancer have higher levels of FOP,and the results of this study revealed a correlation between these four factors.Social support and coping style partially mediated the effects of UI on FOP,and there was a chain-mediating effect between UI and FOP.Programs designed to strengthen social support networks should also incorporate training to develop adaptive coping strategies,ultimately reducing FOP and improving overall quality of life. 展开更多
关键词 Lung cancer Uncertainty in illness Social support Coping style Fear of progression
暂未订购
Glofitamab vs.real-world regimens in Chinese patients with third-or later-line relapsed/refractory diffuse large B-cell lymphoma:an external control study
17
作者 Keshu Zhou Huijing Wu +9 位作者 Xia Zhao Xiaohong Tan Xiaojing Yan Haisheng Liu Liping Su Yukun Lan Jaihui Xu Xiaohui Zhou Yuerong Shuang Huilai Zhang 《Cancer Biology & Medicine》 2025年第10期1218-1222,I0015-I0022,共13页
Diffuse large B-cell lymphoma(DLBCL),the most common subtype of non-Hodgkin’s lymphoma(NHL)worldwide,accounts for 39% and 44% of nodal and extranodal NHL cases in China,respectively1.Standard first-line treatment for... Diffuse large B-cell lymphoma(DLBCL),the most common subtype of non-Hodgkin’s lymphoma(NHL)worldwide,accounts for 39% and 44% of nodal and extranodal NHL cases in China,respectively1.Standard first-line treatment for DLBCL is chemo-immunotherapy with rituximab,cyclophos-phamide,doxorubicin,vincristine,and prednisone,which cures 50%-60% of patients2. 展开更多
关键词 glofitamab real world regimens third later line diffuse large b cell lymphoma external control study relapsed refractory Chinese patients
暂未订购
IL-22/IL-22R1 pathway enhances cholangiocarcinoma progression via ERK1/2 activation
18
作者 Jin Zhou Jing-Rui Chen +7 位作者 Jin-Ming Li Shuang-Qing Han Xi-Yue Deng Zhong-Min Li Wen Tong Chao Wang Yi Bai Ya-Min Zhang 《World Journal of Gastrointestinal Oncology》 2025年第3期246-269,共24页
BACKGROUND IL-22 plays a pivotal role in the processes of inflammation and tissue healing.,but its role in cholangiocarcinoma(CCA)remains unclear.our study explored the IL-22/IL-22R1 pathway and its impact on CCA prog... BACKGROUND IL-22 plays a pivotal role in the processes of inflammation and tissue healing.,but its role in cholangiocarcinoma(CCA)remains unclear.our study explored the IL-22/IL-22R1 pathway and its impact on CCA progression through the ERK1/2 signaling cascade.AIM To determine the mechanism of the IL-22/IL-22R1 pathway in CCA and provide new directions for its clinical treatment.METHODS IL-22R1 expression was assessed in human and rat CCA tissues utilizing immunohistochemical techniques,Western blot analysis,and quantitative reverse transcription PCR.The impact of IL-22 on CCA cells was assessed in vitro via tests for proliferation,migration,invasion,and apoptosis assays.The rat models of thioacetamide-induced CCA and subcutaneous xenografts in nude mice were used to assess the in vivo effects.ERK1/2 inhibitors were applied to elucidate the mechanistic role of the pathway.RESULTS IL-22R1 was overexpressed in CCA cell lines and tissues.IL-22 treatment increased the phosphorylation of ERK1/2,promoting tumor cell proliferation,migration,invasion,and resistance to apoptosis.ERK1/2 inhibition considerably reversed these effects both in vitro and in vivo.CONCLUSION The IL-22/IL-22R1 axis promotes CCA progression by activating ERK1/2 signaling.Targeting this pathway with ERK1/2 inhibitors offers potential therapeutic strategies for CCA. 展开更多
关键词 CHOLANGIOCARCINOMA IL-22 IL-22R1 ERK1/2 Cancer progression
暂未订购
ELMOD2 Overexpression Predicts Adverse Outcomes and Regulates Tumor Progression in Gliomas
19
作者 Rui-chao Li Chang Liu +8 位作者 Guo-jian Wang Zi Wang Rong-lin Li Hao-tian Lu Xiao-xun Xie Qing-mei Zhang Da-qin Feng Xiang Yun Bin Luo 《Current Medical Science》 2025年第3期549-561,共13页
Objective Glioma is a highly heterogeneous and malignant intracranial tumor that presents challenges for clinical treatment.ELMO domain containing 2(ELMOD2)is a GTPase-activating protein that regulates a range of cell... Objective Glioma is a highly heterogeneous and malignant intracranial tumor that presents challenges for clinical treatment.ELMO domain containing 2(ELMOD2)is a GTPase-activating protein that regulates a range of cellular biological processes.However,its specific role and prognostic value in tumorigenesis are still unknown.This study aimed to assess the prognostic relevance and signaling function of ELMOD2 in gliomas.Methods The Chinese Glioma Genome Atlas(CGGA)and The Cancer Genome Atlas(TCGA)databases were utilized to conduct a comprehensive analysis of the expression profile of ELMOD2 in gliomas,elucidating its associations with clinicopathological parameters and patient prognosis.Single-cell analysis was performed to characterize ELMOD2 expression across distinct glioma cell subpopulations.Gene Ontology(GO),Kyoto Encyclopedia of Genes and Genomes(KEGG)enrichment analyses,and Gene Set Variation Analysis(GSVA)were employed to evaluate the potential biological functions of ELMOD2 in gliomagenesis.Specific small interfering RNAs(siRNAs)were used to knock down ELMOD2 in the glioma cell lines U251 and A172 to assess their cellular behaviors and examine the levels of multiple key signaling molecules associated with the occurrence of gliomas.Results ELMOD2 was overexpressed in gliomas,and this upregulation was correlated with tumor grade,isocitrate dehydrogenase mutation,and 1p/19q codeletion status.Notably,ELMOD2 expression was elevated in classical and mesenchymal subtypes,and single-cell resolution analysis revealed predominant enrichment within malignant cells.Functionally,ELMOD2 regulated cell cycle progression,and its overexpression was related to independent adverse outcomes.In vitro experiments revealed that ELMOD2 was located in the cytoplasm and nucleoplasm.Furthermore,ELMOD2 knockdown reduced proliferation,migration,and invasion and increased apoptosis in U251 and A172 cell lines.Finally,ELMOD2 knockdown significantly decreased p-Erk1/2.Conclusions ELMOD2 expression in glioma is positively correlated with tumorigenesis and is a crucial independent prognostic marker.Thus,ELMOD2 is a promising biomarker and therapeutic target for glioma treatment. 展开更多
关键词 ELMO domain containing 2 GLIOMA Prognostic marker Tumor progression Cell cycle regulation GTPase-activating protein
暂未订购
Phase I clinical study of humanized BCMA-single-domain antibodies targeting CAR-T in patients with relapsed or refractory multiple myeloma
20
作者 Gaofeng Zheng Ruyi Xu +6 位作者 Heng Mei Xiaoyan Han Donghua He Yanling Weng Cheng Wen Zhuoxiao Cao Zhen Cai 《Cancer Biology & Medicine》 2025年第11期1377-1380,共4页
Multiple myeloma(MM),one of the most common hemato logical neoplasms worldwide,originates from malignant plasma cells in the bone marrow.MM remains an incurable disease,although continued treatment advancements have m... Multiple myeloma(MM),one of the most common hemato logical neoplasms worldwide,originates from malignant plasma cells in the bone marrow.MM remains an incurable disease,although continued treatment advancements have markedly increased overall survival.Many patients with MM eventually experience relapse or become treatment-refractory1.Patients with relapsed or refractory multiple myeloma(RRMM)become progressively more challenging to manage and have poor prognosis2. 展开更多
关键词 CAR T relapsed refractory multiple myeloma bone marrowmm phase I clinical study hemato logical neoplasms multiple myeloma rrmm become malignant plasma cells multiple myeloma mm one
暂未订购
上一页 1 2 250 下一页 到第
使用帮助 返回顶部